Rafarma Pharmaceuticals Pink Sheet Forecast - Daily Balance Of Power
RAFA Stock | USD 0.07 0.01 16.25% |
Rafarma Pink Sheet Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Rafarma Pharmaceuticals stock prices and determine the direction of Rafarma Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Rafarma Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Rafarma |
Check Rafarma Pharmaceuticals Volatility | Backtest Rafarma Pharmaceuticals | Trend Details |
Rafarma Pharmaceuticals Trading Date Momentum
On December 04 2024 Rafarma Pharmaceuticals was traded for 0.09 at the closing time. The top price for the day was 0.1 and the lowest listed price was 0.08 . The trading volume for the day was 21 K. The trading history from December 4, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 12.37% . The trading delta at closing time against the current closing price is 17.53% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
Compare Rafarma Pharmaceuticals to competition |
Other Forecasting Options for Rafarma Pharmaceuticals
For every potential investor in Rafarma, whether a beginner or expert, Rafarma Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Rafarma Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Rafarma. Basic forecasting techniques help filter out the noise by identifying Rafarma Pharmaceuticals' price trends.Rafarma Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rafarma Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Rafarma Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Rafarma Pharmaceuticals by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Rafarma Pharmaceuticals Technical and Predictive Analytics
The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Rafarma Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Rafarma Pharmaceuticals' current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Rafarma Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Rafarma Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rafarma Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Rafarma Pharmaceuticals pink sheet market strength indicators, traders can identify Rafarma Pharmaceuticals entry and exit signals to maximize returns.
Rafarma Pharmaceuticals Risk Indicators
The analysis of Rafarma Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Rafarma Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting rafarma pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 9.51 | |||
Semi Deviation | 11.92 | |||
Standard Deviation | 15.7 | |||
Variance | 246.49 | |||
Downside Variance | 354.21 | |||
Semi Variance | 142.18 | |||
Expected Short fall | (14.80) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Rafarma Pink Sheet
Rafarma Pharmaceuticals financial ratios help investors to determine whether Rafarma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rafarma with respect to the benefits of owning Rafarma Pharmaceuticals security.